Nifty

:

25935.15

Sensex

:

84273.92

67.85 (0.26%)
208.17 (0.25%)

Login

Nifty
Sensex

:
:

25935.15
84273.92

67.85 (0.26%)
208.17 (0.25%)

FDC Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

55/99

BSE: 531599 | NSE: FDC

Watchlist

NSE BSE

397.10

10-Feb-2026

Open
High
Low
Previous Close

384.9
399
383.75
384.75

Volume
Traded Value (lacs)
52 Week High
52 Week Low

115064
45306248.65
527.8
357.55

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,475.77
29.88
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,439.32
1.26%
2.63

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.80
9.60
5.73

EBITDA CAGR (%)

10 Years
5 Years
3 Years

3.57
-0.56
5.41

PAT CAGR (%)

10 Years
5 Years
3 Years

4.66
-2.41
11.20

P:E (Median)

8 Years
5 Years
3 Years

23.07
25.36
26.57

P:BV (Average)

8 Years
5 Years
3 Years

2.92
2.97
3.18

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.69
15.92
17.49

Earnings Forecasts:

(Updated: 07-02-2026)

Description 2024 2025 2026 2027
Adj EPS 16.39
P/E Ratio 24.23
Revenue 2102.57
EBITDA 324.8
Net Income 266.79
ROA 10.3
P/B Ratio 2.83
ROE 12.19
FCFF 267.43
FCFF Yield 4.63
Net Debt -515.67
BVPS 140.11

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 457.94 458.86 -0.20% 461.74 505.10 -8.58% 642.28 624.14 2.91% 482.00 454.23 6.11%
Expenses 408.33 412.92 -1.11% 426.85 432.70 -1.35% 500.94 482.45 3.83% 429.18 396.39 8.27%
EBITDA 49.61 45.94 7.99% 34.89 72.40 -51.81% 141.34 141.69 -0.25% 52.83 57.84 -8.66%
EBIDTM 10.83% 10.01% 7.56% 14.33% 22.01% 22.70% 10.96% 12.73%
Other Income 22.07 18.64 18.40% 20.91 34.68 -39.71% 35.59 28.15 26.43% 31.43 20.72 51.69%
Interest 1.12 0.94 19.15% 1.15 1.07 7.48% 1.16 1.29 -10.08% 1.18 0.94 25.53%
Depreciation 14.75 13.32 10.74% 15.17 13.76 10.25% 14.88 11.00 35.27% 15.53 10.39 49.47%
PBT 35.02 50.32 -30.41% 39.49 92.25 -57.19% 160.88 157.56 2.11% 67.54 67.22 0.48%
Tax 7.83 13.87 -43.55% 10.02 18.28 -45.19% 38.69 42.57 -9.11% 19.33 19.02 1.63%
PAT 27.19 36.45 -25.40% 29.48 73.97 -60.15% 122.19 114.99 6.26% 48.21 48.20 0.02%
PATM 5.94% 7.94% 6.38% 14.65% 19.02% 18.42% 10.00% 10.61%
EPS 1.67 2.24 -25.45% 1.81 4.54 -60.13% 7.51 7.06 6.37% 2.96 2.96 0.00%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 464.71 464.11 0.13% 473.03 513.85 -7.94% 648.41 638.27 1.59% 491.89 462.03 6.46%
Expenses 412.43 417.46 -1.20% 439.21 443.69 -1.01% 508.06 491.65 3.34% 437.91 405.71 7.94%
EBITDA 52.28 46.65 12.07% 33.82 70.16 -51.80% 140.34 146.62 -4.28% 53.98 56.33 -4.17%
EBIDTM 11.25% 10.05% 7.15% 13.65% 21.64% 22.97% 10.97% 12.19%
Other Income 20.80 18.83 10.46% 20.62 34.70 -40.58% 35.50 28.44 24.82% 16.08 20.27 -20.67%
Interest 1.12 0.95 17.89% 1.15 1.07 7.48% 1.17 1.30 -10.00% 1.19 0.95 25.26%
Depreciation 14.78 13.36 10.63% 15.20 13.79 10.22% 14.91 11.02 35.30% 15.56 10.44 49.04%
PBT 36.38 51.18 -28.92% 38.09 90.00 -57.68% 159.78 162.73 -1.81% 53.31 65.21 -18.25%
Tax 8.08 14.14 -42.86% 9.72 17.96 -45.88% 38.42 43.70 -12.08% 14.64 18.93 -22.66%
PAT 28.30 37.04 -23.60% 28.37 72.04 -60.62% 121.35 119.04 1.94% 38.67 46.28 -16.44%
PATM 6.09% 7.98% 6.00% 14.02% 18.72% 18.65% 7.86% 10.02%
EPS 1.74 2.27 -23.35% 1.74 4.42 -60.63% 7.45 7.31 1.92% 2.38 2.84 -16.20%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,043.96 2,070.11 1,916.19 1,777.03 1,518.97 1,325.45 1,331.09 1,075.87 1,062.20 1,008.91 986.81 Net Sales Growth 0.08% 8.03% 7.83% 16.99% 14.60% -0.42% 23.72% 1.29% 5.28% 2.24% Cost Of Goods Sold 658.74 724.39 645.81 654.26 527.84 412.05 424.53 344.49 349.98 338.09 355.07 Gross Profit 1,385.22 1,345.72 1,270.37 1,122.77 991.12 913.40 906.56 731.39 712.22 670.81 631.74 GP Margin 67.77% 65.01% 66.30% 63.18% 65.25% 68.91% 68.11% 67.98% 67.05% 66.49% 64.02% Total Expenditure 1,765.30 1,749.86 1,577.73 1,523.84 1,272.12 1,001.12 1,047.51 855.83 843.10 766.96 759.85 Power & Fuel Cost - 39.38 37.38 34.08 28.89 27.06 27.38 24.60 21.98 21.52 23.12 % Of Sales - 1.90% 1.95% 1.92% 1.90% 2.04% 2.06% 2.29% 2.07% 2.13% 2.34% Employee Cost - 477.22 408.99 386.99 339.97 294.31 276.18 226.19 215.47 189.93 174.53 % Of Sales - 23.05% 21.34% 21.78% 22.38% 22.20% 20.75% 21.02% 20.29% 18.83% 17.69% Manufacturing Exp. - 165.28 170.27 154.77 128.20 77.94 68.76 62.19 58.70 49.34 36.39 % Of Sales - 7.98% 8.89% 8.71% 8.44% 5.88% 5.17% 5.78% 5.53% 4.89% 3.69% General & Admin Exp. - 110.16 103.67 99.60 69.39 54.95 57.18 58.56 60.53 52.70 49.55 % Of Sales - 5.32% 5.41% 5.60% 4.57% 4.15% 4.30% 5.44% 5.70% 5.22% 5.02% Selling & Distn. Exp. - 200.97 181.93 168.58 147.47 87.68 94.70 78.94 75.96 64.36 57.73 % Of Sales - 9.71% 9.49% 9.49% 9.71% 6.62% 7.11% 7.34% 7.15% 6.38% 5.85% Miscellaneous Exp. - 32.46 29.68 25.56 30.36 47.13 98.78 60.87 60.47 50.99 57.73 % Of Sales - 1.57% 1.55% 1.44% 2.00% 3.56% 7.42% 5.66% 5.69% 5.05% 6.43% EBITDA 278.67 320.25 338.46 253.19 246.85 324.33 283.58 220.04 219.10 241.95 226.96 EBITDA Margin 13.63% 15.47% 17.66% 14.25% 16.25% 24.47% 21.30% 20.45% 20.63% 23.98% 23.00% Other Income 110.00 105.52 103.22 55.29 78.73 97.15 82.66 54.80 51.25 49.65 39.98 Interest 4.61 4.49 4.00 4.04 3.05 3.40 3.41 1.43 1.40 1.41 1.40 Depreciation 60.33 53.61 39.73 38.76 37.08 37.62 37.36 33.14 35.04 34.52 33.61 PBT 302.93 367.67 397.95 265.69 285.45 380.45 325.46 240.27 233.91 255.67 231.94 Tax 75.87 94.05 90.78 64.72 65.82 85.96 78.68 64.76 65.59 62.72 63.03 Tax Rate 25.05% 25.58% 22.81% 24.36% 23.06% 22.59% 24.18% 27.41% 28.04% 25.11% 27.18% PAT 227.07 273.63 307.16 200.97 219.64 294.49 246.78 171.54 168.31 187.07 168.90 PAT before Minority Interest 227.07 273.63 307.16 200.97 219.64 294.49 246.78 171.54 168.31 187.07 168.90 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.11% 13.22% 16.03% 11.31% 14.46% 22.22% 18.54% 15.94% 15.85% 18.54% 17.12% PAT Growth -17.01% -10.92% 52.84% -8.50% -25.42% 19.33% 43.86% 1.92% -10.03% 10.76% EPS 13.95 16.81 18.87 12.34 13.49 18.09 15.16 10.54 10.34 11.49 10.37

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,078.04 2,108.12 1,942.94 1,783.75 1,527.92 1,333.20 1,344.19 1,090.70 1,075.07 1,013.87 994.32 Net Sales Growth -0.01% 8.50% 8.92% 16.74% 14.61% -0.82% 23.24% 1.45% 6.04% 1.97% Cost Of Goods Sold 666.70 736.27 656.15 655.79 530.21 414.07 425.72 345.14 352.08 339.05 357.93 Gross Profit 1,411.34 1,371.84 1,286.79 1,127.96 997.71 919.14 918.46 745.56 722.99 674.81 636.38 GP Margin 67.92% 65.07% 66.23% 63.24% 65.30% 68.94% 68.33% 68.36% 67.25% 66.56% 64.00% Total Expenditure 1,797.61 1,783.32 1,604.41 1,534.16 1,274.23 999.15 1,051.25 859.68 848.38 770.40 765.58 Power & Fuel Cost - 39.38 37.38 34.12 28.91 27.08 27.40 24.61 22.00 21.55 23.14 % Of Sales - 1.87% 1.92% 1.91% 1.89% 2.03% 2.04% 2.26% 2.05% 2.13% 2.33% Employee Cost - 482.37 413.40 390.90 343.33 296.29 277.48 225.57 216.67 191.08 175.76 % Of Sales - 22.88% 21.28% 21.91% 22.47% 22.22% 20.64% 20.68% 20.15% 18.85% 17.68% Manufacturing Exp. - 165.33 171.89 154.81 128.24 77.97 68.80 62.25 58.77 49.40 36.44 % Of Sales - 7.84% 8.85% 8.68% 8.39% 5.85% 5.12% 5.71% 5.47% 4.87% 3.66% General & Admin Exp. - 114.49 107.33 101.01 70.29 55.64 58.06 59.45 61.55 53.35 49.97 % Of Sales - 5.43% 5.52% 5.66% 4.60% 4.17% 4.32% 5.45% 5.73% 5.26% 5.03% Selling & Distn. Exp. - 211.27 187.19 171.01 147.96 87.74 94.70 78.92 75.96 64.36 57.73 % Of Sales - 10.02% 9.63% 9.59% 9.68% 6.58% 7.05% 7.24% 7.07% 6.35% 5.81% Miscellaneous Exp. - 34.20 31.06 26.53 25.28 40.37 99.07 63.73 61.35 51.61 57.73 % Of Sales - 1.62% 1.60% 1.49% 1.65% 3.03% 7.37% 5.84% 5.71% 5.09% 6.50% EBITDA 280.42 324.80 338.53 249.59 253.69 334.05 292.94 231.02 226.69 243.47 228.74 EBITDA Margin 13.49% 15.41% 17.42% 13.99% 16.60% 25.06% 21.79% 21.18% 21.09% 24.01% 23.00% Other Income 93.00 90.66 101.63 51.24 76.09 97.03 68.90 43.47 50.96 50.22 39.00 Interest 4.63 4.51 4.03 4.09 3.09 3.43 3.42 1.44 1.40 1.41 1.40 Depreciation 60.45 53.73 39.92 38.94 37.30 37.81 37.46 33.24 35.14 34.62 33.73 PBT 287.56 357.22 396.22 257.80 289.39 389.83 320.97 239.80 241.11 257.65 232.62 Tax 70.86 90.43 91.16 63.98 73.23 86.53 80.08 66.85 67.12 63.30 63.48 Tax Rate 24.64% 25.31% 23.01% 24.82% 25.30% 22.32% 24.95% 28.01% 27.84% 25.14% 27.29% PAT 216.69 266.79 305.06 194.04 216.40 301.33 240.89 171.85 173.99 188.47 169.14 PAT before Minority Interest 216.69 266.79 305.06 193.83 216.16 301.18 240.89 171.85 173.99 188.47 169.14 Minority Interest 0.00 0.00 0.00 0.21 0.24 0.15 0.00 0.00 0.00 0.00 0.00 PAT Margin 10.43% 12.66% 15.70% 10.88% 14.16% 22.60% 17.92% 15.76% 16.18% 18.59% 17.01% PAT Growth -21.03% -12.55% 57.22% -10.33% -28.19% 25.09% 40.17% -1.23% -7.68% 11.43% EPS 13.31 16.39 18.74 11.92 13.29 18.51 14.80 10.56 10.69 11.58 10.39

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,287.19 2,097.20 1,980.74 1,948.69 1,722.17 1,541.82 1,433.04 1,262.40 1,263.72 1,076.53 Share Capital 16.28 16.28 16.59 16.88 16.88 17.10 17.52 17.52 17.86 17.86 Total Reserves 2,270.91 2,080.92 1,964.15 1,931.80 1,705.28 1,524.72 1,415.52 1,244.88 1,245.86 1,058.67 Non-Current Liabilities 808.92 597.62 462.65 384.43 299.56 314.62 229.17 211.41 216.67 19.93 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.03 0.11 0.21 0.34 0.49 0.60 0.69 0.79 Long Term Provisions 776.87 574.35 436.75 349.81 281.24 295.78 213.96 194.12 198.60 0.50 Current Liabilities 543.70 612.23 728.67 688.60 620.07 562.37 494.21 476.08 387.41 162.11 Trade Payables 201.52 184.63 178.48 136.26 76.66 117.54 77.20 96.95 74.66 82.30 Other Current Liabilities 122.59 99.96 95.93 85.87 76.83 79.53 60.88 66.76 63.10 49.58 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 219.60 327.64 454.27 466.47 466.59 365.29 356.13 312.37 249.65 30.24 Total Liabilities 3,639.81 3,307.05 3,172.06 3,021.72 2,641.80 2,418.81 2,156.42 1,949.89 1,867.80 1,258.57 Net Block 847.50 676.39 694.93 700.97 685.02 669.77 678.47 669.75 674.50 670.89 Gross Block 1,175.85 985.51 971.79 942.26 890.57 840.73 813.68 772.29 742.10 704.26 Accumulated Depreciation 328.35 309.12 276.86 241.29 205.56 170.96 135.21 102.53 67.61 33.36 Non Current Assets 2,383.07 1,947.92 1,730.32 1,615.15 1,299.40 1,177.74 1,109.97 973.09 954.70 738.52 Capital Work in Progress 136.17 260.88 197.84 104.36 19.21 23.85 12.38 12.84 6.32 19.92 Non Current Investment 565.07 399.70 348.71 384.95 265.58 162.53 179.33 74.40 54.82 39.76 Long Term Loans & Adv. 833.19 609.50 487.39 424.04 326.63 320.83 239.08 215.28 218.46 7.70 Other Non Current Assets 1.13 1.45 1.45 0.84 2.96 0.75 0.71 0.81 0.60 0.25 Current Assets 1,253.32 1,355.13 1,439.89 1,406.56 1,342.39 1,241.06 1,046.45 976.80 913.10 520.05 Current Investments 484.65 450.03 457.29 500.77 524.84 502.24 405.93 397.16 436.53 285.41 Inventories 367.70 383.47 323.34 303.63 213.27 209.49 172.73 159.65 136.22 130.24 Sundry Debtors 103.88 114.61 121.25 79.71 107.80 124.19 83.52 76.71 77.46 64.03 Cash & Bank 40.97 21.65 20.80 32.06 26.86 28.96 15.70 21.12 23.02 13.50 Other Current Assets 256.11 20.11 12.26 11.46 469.61 376.17 368.57 322.16 239.86 26.88 Short Term Loans & Adv. 241.48 365.27 504.94 478.94 450.07 349.81 357.56 311.65 230.44 20.30 Net Current Assets 709.62 742.91 711.22 717.96 722.33 678.69 552.24 500.72 525.69 357.93 Total Assets 3,636.39 3,303.05 3,170.21 3,021.71 2,641.79 2,418.80 2,156.42 1,949.89 1,867.80 1,258.57

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,281.08 2,097.17 1,982.05 1,956.79 1,734.13 1,547.43 1,445.24 1,276.11 1,270.20 1,082.47 Share Capital 16.28 16.28 16.59 16.88 16.88 17.10 17.52 17.52 17.86 17.86 Total Reserves 2,264.80 2,080.89 1,965.46 1,939.91 1,717.25 1,530.33 1,427.72 1,258.59 1,252.34 1,064.61 Non-Current Liabilities 811.89 604.16 468.64 391.17 299.63 314.62 229.17 211.41 216.67 19.93 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.11 0.25 0.56 0.65 0.72 0.34 0.49 0.60 0.69 0.79 Long Term Provisions 776.87 574.35 436.75 349.81 281.24 295.78 213.96 194.12 198.60 0.50 Current Liabilities 550.33 615.18 729.56 690.40 621.79 564.62 497.43 480.07 389.40 163.42 Trade Payables 205.15 186.03 178.49 136.94 77.28 117.86 77.61 97.32 75.10 82.59 Other Current Liabilities 124.62 101.50 96.59 86.44 77.36 80.06 61.67 68.78 64.11 50.16 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 220.56 327.64 454.48 467.01 467.15 366.69 358.15 313.97 250.19 30.67 Total Liabilities 3,643.30 3,316.51 3,179.61 3,037.93 2,655.38 2,426.67 2,171.84 1,967.59 1,876.27 1,265.82 Net Block 851.55 680.26 698.92 705.06 689.15 673.50 682.19 673.64 678.05 675.16 Gross Block 1,181.74 987.18 973.27 949.42 897.55 844.97 817.80 776.49 745.84 708.81 Accumulated Depreciation 330.19 306.92 274.35 244.36 208.40 171.47 135.61 102.84 67.79 33.65 Non Current Assets 2,365.89 1,945.46 1,734.70 1,619.50 1,303.33 1,181.25 1,113.46 976.64 957.93 742.46 Capital Work in Progress 136.84 261.48 198.44 104.82 19.21 23.85 12.38 12.84 6.32 19.92 Non Current Investment 543.17 392.76 348.49 384.73 265.36 162.31 179.11 74.07 54.49 39.43 Long Term Loans & Adv. 833.20 609.51 487.41 424.05 326.65 320.83 239.08 215.28 218.46 7.70 Other Non Current Assets 1.13 1.45 1.45 0.84 2.96 0.75 0.71 0.81 0.60 0.25 Current Assets 1,273.98 1,367.05 1,443.06 1,418.43 1,352.05 1,245.41 1,058.38 990.94 918.34 523.36 Current Investments 484.65 450.03 457.29 500.77 524.84 502.24 405.93 397.16 436.53 285.41 Inventories 375.03 388.89 328.54 304.70 214.92 209.96 173.79 160.49 137.16 130.91 Sundry Debtors 108.85 117.38 122.65 82.17 110.54 123.74 87.53 81.66 76.06 61.94 Cash & Bank 52.77 26.29 24.94 38.66 31.58 32.32 21.26 29.30 28.47 18.02 Other Current Assets 252.68 19.19 9.94 11.70 470.17 377.15 369.88 322.33 240.12 27.10 Short Term Loans & Adv. 241.57 365.27 499.69 480.43 450.41 350.34 358.56 311.65 230.44 20.36 Net Current Assets 723.65 751.87 713.50 728.03 730.26 680.79 560.94 510.87 528.94 359.94 Total Assets 3,639.87 3,312.51 3,177.76 3,037.93 2,655.38 2,426.66 2,171.84 1,967.58 1,876.27 1,265.82

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 310.34 220.81 164.72 162.38 209.84 239.04 103.79 147.76 153.09 171.09 PBT 367.67 397.95 265.69 285.45 380.45 325.46 240.27 233.91 255.67 231.94 Adjustment -39.91 -52.32 1.00 -23.59 -40.75 8.36 -13.54 -1.86 -11.07 0.24 Changes in Working Capital 85.40 -21.91 -25.11 -21.17 -36.05 -11.00 -51.34 -16.54 -18.76 -5.75 Cash after chg. in Working capital 413.16 323.71 241.58 240.69 303.65 322.82 175.38 215.50 225.84 226.42 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -102.82 -102.90 -76.86 -78.31 -93.81 -83.78 -71.60 -67.75 -69.78 -55.33 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.97 0.00 Cash From Investing Activity -199.45 -17.76 3.62 -147.42 -84.18 -84.80 -109.30 20.15 -143.55 -72.76 Net Fixed Assets -65.63 -76.76 -123.01 -136.84 -45.20 -38.52 -40.93 -36.71 -24.24 -81.62 Net Investments -199.99 -43.73 79.72 -95.30 -125.65 -79.51 -113.70 19.79 -166.18 170.44 Others 66.17 102.73 46.91 84.72 86.67 33.23 45.33 37.07 46.87 -161.58 Cash from Financing Activity -92.10 -202.03 -179.83 -9.70 -126.49 -142.00 -0.07 -169.43 0.35 -96.98 Net Cash Inflow / Outflow 18.79 1.02 -11.48 5.26 -0.83 12.24 -5.58 -1.53 9.90 1.36 Opening Cash & Equivalents 20.77 19.75 31.13 25.72 26.52 14.36 19.94 21.66 11.74 10.58 Closing Cash & Equivalent 39.67 20.77 19.75 31.13 25.72 26.52 14.36 19.94 21.66 11.74

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 317.57 220.77 154.91 161.65 207.08 250.38 112.43 149.84 154.49 174.30 PBT 357.22 396.22 257.80 289.39 389.85 319.95 237.75 240.63 257.71 232.15 Adjustment -24.78 -51.18 4.32 -26.48 -48.34 22.58 -0.21 0.39 -10.88 2.41 Changes in Working Capital 87.94 -20.35 -29.91 -21.72 -39.42 -7.77 -51.05 -23.24 -19.23 -4.54 Cash after chg. in Working capital 420.37 324.69 232.21 241.19 302.09 334.77 186.49 217.78 227.60 230.02 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -102.80 -103.92 -77.30 -79.54 -95.01 -84.39 -74.06 -67.94 -70.14 -55.73 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.97 0.00 Cash From Investing Activity -199.51 -17.08 11.13 -144.57 -77.15 -98.35 -120.33 20.11 -143.55 -73.05 Net Fixed Assets -65.63 -76.76 -123.01 -136.84 -45.20 -38.52 -40.93 -36.71 -24.24 -81.62 Net Investments -199.99 -43.73 79.72 -95.30 -125.65 -79.51 -113.70 19.79 -166.18 170.44 Others 66.11 103.41 54.42 87.57 93.70 19.68 34.30 37.03 46.87 -161.87 Cash from Financing Activity -92.12 -202.16 -179.95 -9.84 -129.35 -142.00 -0.07 -169.43 0.35 -96.98 Net Cash Inflow / Outflow 25.94 1.53 -13.90 7.25 0.58 10.03 -7.96 0.52 11.29 4.27 Opening Cash & Equivalents 25.42 23.89 37.73 30.43 29.88 19.92 28.13 27.10 16.25 12.17 Closing Cash & Equivalent 51.47 25.42 23.89 37.73 30.43 29.88 19.92 28.13 27.10 16.25

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 140.48 128.81 119.39 115.44 102.02 90.18 82.16 72.38 71.06 60.53 ROA 7.88% 9.48% 6.49% 7.76% 11.64% 10.79% 8.35% 8.82% 11.97% 14.09% ROE 12.48% 15.06% 10.23% 11.97% 18.04% 16.59% 12.73% 13.33% 15.99% 16.85% ROCE 16.98% 19.71% 13.70% 15.66% 23.43% 22.06% 17.63% 18.62% 21.45% 23.25% Fixed Asset Turnover 1.98 2.02 1.91 1.71 1.57 1.65 1.39 1.41 1.45 1.53 Receivable days 18.66 21.82 20.01 21.87 31.18 27.76 26.53 26.29 24.69 22.54 Inventory Days 64.14 65.39 62.44 60.30 56.83 51.08 55.04 50.45 46.49 45.50 Payable days 97.28 102.61 87.79 73.61 86.01 38.13 40.20 41.31 40.79 44.71 Cash Conversion Cycle -14.49 -15.40 -5.34 8.56 2.00 40.71 41.37 35.43 30.39 23.32 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 82.92 100.49 66.79 94.65 112.82 96.31 166.02 167.77 178.52 167.05

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 140.11 128.81 119.47 115.92 102.73 90.51 82.86 73.17 71.42 60.87 ROA 7.67% 9.39% 6.23% 7.59% 11.85% 10.48% 8.30% 9.05% 12.00% 14.01% ROE 12.19% 14.96% 9.84% 11.71% 18.36% 16.10% 12.63% 13.67% 16.02% 16.76% ROCE 16.52% 19.62% 13.27% 15.78% 23.74% 21.63% 17.64% 19.04% 21.51% 23.15% Fixed Asset Turnover 2.01 2.04 1.91 1.70 1.57 1.66 1.41 1.42 1.44 1.52 Receivable days 18.98 21.91 20.32 22.35 31.31 27.96 27.55 26.58 23.96 22.06 Inventory Days 64.09 65.48 62.83 60.27 56.79 50.80 54.43 50.15 46.55 45.58 Payable days 96.96 101.39 87.78 73.73 86.01 38.19 40.35 41.32 40.83 44.81 Cash Conversion Cycle -13.89 -14.00 -4.62 8.89 2.09 40.57 41.62 35.41 29.68 22.84 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 80.21 99.22 64.07 94.67 113.90 94.95 166.95 172.62 179.60 167.11

Top Investors:

icici prudential smallcap fund

nippon life india trustee ltd-a/c nippon india small cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

FDC - Quarterly Results
6th Feb 2026, 00:00 AM

Read More
FDC secures USFDA’s nod for Fluconazole Tablets
9th Jan 2026, 12:30 PM

The company has received abbreviated new drug application approval from USFDA
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback